Nov./Dec. 2017

Letter from the Editor

November 20, 2017

Warp Speed Ahead It’s that time of year again — time to pause, reflect, and take stock of the year that was, while gearing up for the wild ride that lies ahead. This time last year, we had just elected a new president, and today there remains quite a bit of uncertainty as to what […]

Upfront

November 20, 2017

Pfizer Service Provides Social Workers for Patients Pfizer Oncology Together is a first-of-its-kind offering for patients taking Pfizer Oncology medicines. The program offers dedicated social workers called “Care Champions” to help navigate the complexities that accompany treatment, such as identifying resources to help find emotional support, and workplace transition, transportation, and financial assistance. Pfizer has […]

HealthTech

November 20, 2017

LivaNova Receives FDA Approvals for SenTiva Device for Treatment of Epilepsy Trend Watch: Health Technology Increases Wellness Across Epilepsy, Autism, and Weight Loss LivaNova, a market-leading medical technology company, has received FDA approval for its latest vagus nerve stimulation therapy (VNS Therapy) system, which consists of the SenTiva implantable generator and the next-generation VNS therapy […]

Last Word

November 20, 2017

Digital Health Initiatives Georgia Mitsi, Senior Director, Search Evaluation & Digital Health Care Initiatives, at Sunovion Pharmaceuticals, discusses the company’s digital health efforts. PV: What is the driving force behind the many digital health initiatives at Sunovion? Mitsi: Sunovion’s intent is to continue to access digital technologies designed first and foremost to help patients. At […]

Trend Tracking

November 20, 2017

In this special — 2018 Year in Preview — issue, PharmaVOICE’s thought leaders are tackling 10 trends that are expected to incite change in the year ahead. We will be looking at a variety of disparate topics that range from molecule to market in keeping with our publishing focus and philosophy: 2018 Year in Preview […]

Trending 2018: What Does the Future Hold?

November 20, 2017

We tasked the PharmaVOICE 100 community of industry executives to think about some of the most important trends they expect will challenge the status quo, move the industry forward, and contribute to breakthroughs in medicine and business models. Their thoughtful insights signal the multitude of challenges and opportunities that lie ahead in the coming year. […]

Trending 2018: Agile Marketing

November 20, 2017

Agile methodology is all about leveraging experiences and failures to improve a process, and has been adopted across industries and entities to organize everything from software development to household chores and family activities. Rooted in IT, the agile manifesto has been adopted by winemakers, tractor manufacturers, public radio, and parents. By taking people — employees […]

Trending 2018: Alternative Delivery

November 20, 2017

Point and click — could ordering your prescription drugs be as easy as that? Some experts say yes, some say we’ll see. But there is one thing for sure: the retail pharmacy world is changing. And one disrupter — Amazon — is in the middle of it all. And with Amazon’s mass distribution system, the […]

Trending 2018: Artificial Intelligence

November 20, 2017

Artificial intelligence (AI) in health represents a collection of multiple technologies, enabling machines to sense, comprehend, act, and learn so they can perform administrative and clinical healthcare functions. There are different applications of AI and machine learning in pharma, including disease identification/diagnosis, personalized treatment/behavioral modification, drug discovery/manufacturing, radiology and radiotherapy, smart electronic health records, epidemic […]

Trending 2018: Bioethics

November 20, 2017

New technologies for gene editing have created excitement about the potential for cures for diseases, as well as debates around ethics and regulatory oversight that are sure to dominate this field of science for years to come. CRISPR-Cas9, the newest gene-editing tool, is getting a lot of attention. It uses a protein-RNA complex that has […]

Trending 2018: Brand Engagement

November 20, 2017

As patients start to manage their health through digital devices, not only does the pharma industry need to be more patient-centric, but the brand story must focus on the patient and his or her journey to create true brand engagement. According to a report from DRG Digital, as the pharmaceutical industry shifts its commercial model […]

Trending 2018: Pipeline Disrupters

November 20, 2017

In recent years, several therapeutic disruptors have hit the market, pushing aside current standard treatment protocols. From hepatitis C cures to immuno-oncology therapies, recent approvals have upended how diseases are treated, providing patients with significant advances. Pharmaceutical, biotech, and biopharma companies are working on tomorrow’s disrupters. With more than 7,000 medicines in development around the […]

Trending 2018: Rare Diseases

November 20, 2017

In recent years, a growing number of companies have entered the rare disease space, bolstered by regulatory incentives, such as the Orphan Drug Act, and scientific breakthroughs. While each rare disease has a relatively small patient population — defined in the United States as affecting fewer than 200,000 people — collectively the approximately 7,000 rare […]

Trending 2018: Real-World Outcomes

November 20, 2017

Real-word outcomes is not a new trend by any means, but it’s a market-changing model that is coming into its own and worthy of covering. That’s because the pharmaceutical market continues to shift to an outcomes-based reimbursement system, driven by payers’ need to rein in rising drug prices, advances in health technology, new data sources, […]

Trending 2018: Treatment to Wellness

November 20, 2017

Attitudes about treating disease are undergoing a fundamental shift as the life-sciences industry faces pressure to demonstrate value. Increasingly, there is a move from treatment to prevention, diagnostics and cure, which KPMG says is leading to the rise of new competitors. By 2030, practitioners will be able to predict the likelihood of a patient being […]

Trending 2018: Virtual Health Technology

November 20, 2017

Someday, a bandage controlled by a smart phone could heal chronic wounds. Soon, a body-on-a-chip system could reduce the use of animal testing and more speedily advance personalized medicine. These are just two examples of how innovative technology is creating a new healthcare ecosystem, one in which the pharma industry will have to stretch its […]

SHOWCASE FEATURE: eSolutions: Digital Takes Center Stage

November 20, 2017

Recent trends suggest that pharma companies will continue to invest in digital solutions and partner with innovative technology companies to inform business and clinical decision-making. Yet according to McKinsey, many pharma executives find it hard to determine which digital initiatives to scale up and how. The priority for companies will be to assess which technologies […]

Picture This: Managing the Entire Lifecycle of Clinical Trial Images in a Single Tool

November 20, 2017

One of the great promises of technology is that it can simplify our lives. The need for it to do so is particularly strong in clinical research, where trials have been growing ever more complex. This is due, in part, to regulators’ increasing requests for the inclusion of imaging analysis when evaluating clinical trial data. […]

Digital Solutions That Make Sense to Support Sales Team Initiatives

November 20, 2017

Personal detailing by pharmaceutical sales representatives to physicians and other healthcare professionals has traditionally been the foremost effective way of brand marketing. Reportedly, pharmaceutical companies’ per capita spend on personal detailing visits exceeds direct-to-consumer marketing efforts, research, and development of new products. The sales detail appointment typically consists of a visit where the benefits of […]

Speak Out

November 20, 2017

Innovations in Alzheimer’s Clinical Trial Design Promise to Reduce Time, Risk by Allison House, Therapeutic Strategy Lead, Neuroscience, Worldwide Clinical Trials and Natalia Drosopoulou, Senior Director, Global Project Management, Neuroscience, Worldwide Clinical Trials The global impact of Alzheimer’s disease continues to increase. By 2050, The Alzheimer’s Association expects the number of people diagnosed with dementia […]

Red Zone: Healing Patients With Digital Warmth: A Prescription for Life Sciences

November 20, 2017

Earlier this year, ReD Associates and Cognizant conducted an extensive research that cut across disease areas to understand how patients heal – that is, what happens when people face a health risk or issue and need to manage or overcome it. By participating in people’s everyday lives, we found that most patient experience the US […]

Red Zone: safety portal: Increasing Patient Safety While Reducing Cost and Complexity

November 20, 2017

Although it sounds straightforward, global safety reporting of clinical trial adverse events is complicated, time-consuming and extremely expensive. Despite the substantial investment of time and money, research shows that global safety reporting is not protecting patients as well as it could. Driven by fear of regulatory non-compliance, along with a lack of sophisticated algorithms to […]

Red Zone: Leveraging Behavioral Economics to Guide Healthy Decision-Making

November 20, 2017

People living with long-term health conditions make many decisions about their health, often on a daily basis, including whether to adhere to prescribed treatments. What insights from the world of psychology can help us create effective programs that guide healthy decision-making around adherence? One important insight is a fundamental tenet from the discipline of behavioral […]

Red Zone: Innovation in Hematopoietic Cell Transplantation and Gene and Cellular Therapies Drive Results in Pediatric Oncology

November 20, 2017

This is an exciting time in medicine, providing more novel treatments for patients with cancer blood disorders. Scientists are learning more about the human genome and its role in disease. This knowledge allows investigators to develop new diagnostic tools and therapeutic interventions to more specifically treat individual diseases. We are now identifying ways to correct […]

FEEDBACK